The Global Pharmaceutical Fine Chemicals Market Outlook to 2015

• Publication date: January 2011

Introduction This report provides a comprehensive overview of the global pharmaceutical fine chemicals market including the classification of PFCs, demand/supply dynamics, and the key deals and alliances in the PFC market. The report also analyzes the global PFC industry in terms of market dynamics (market size, drivers and resistors of growth), key merger and acquisitions and recent trends in the industry. Features and be...

Introduction

This report provides a comprehensive overview of the global pharmaceutical fine chemicals market including the classification of PFCs, demand/supply dynamics, and the key deals and alliances in the PFC market. The report also analyzes the global PFC industry in terms of market dynamics (market size, drivers and resistors of growth), key merger and acquisitions and recent trends in the industry.

Features and benefits

* Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure.
* Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market.
* Understand the basic PFC manufacturing processes and the raw materials used in their production.
* Understand how recent trends in the pharmaceutical market are responsible for shaping the trends in the PFC industry.
* Analyze the performance of the leading PFC players and gain an insight into their geographic reach, business segments, revenues, growth strategies.

Highlights

Pharmaceutical fine chemicals are chemicals used in the manufacture of pharmaceutical products. The pharmaceutical industry being one of the largest clients of PFC industry, not only affects the sales dynamics of the PFC industry, but also catalyses certain trends in this industry.
The relative importance of India and China as manufacturing areas for fine chemicals and pharmaceutical APIs has increased over recent decades because of the cost benefits that these countries offer to the pharmaceutical companies.
The drive towards cost reduction in the pharmaceutical industry will continue to create pricing pressure on the fine chemicals industry. Moreover, the consolidation of the pharmaceutical sector will also reduce the number of potential customers for the PFC industry.

Your Key questions answered

* What is the market size and growth rate of the global pharmaceutical fine chemicals market?
* What are the main trends driving the growth of the global PFC market and how is the ‘patent cliff’ impacting PFC sales?
* Which are the key deals and alliances in the global PFC industry and how will they impact the stakeholders?
* Which are the leading players in the global PFC market and what are their growth strategies?
* What are the key technological developments in the global PFC market?

Global Chemical Industry

Table of Contents
About Business Insights 2
Disclaimer 2
Executive summary 9
Industry overview 9
Market overview 10
Recent trends in the pharmaceutical fine chemicals industry 11
Competitive landscape 11
Scope and methodology 13
Scope 13
Methodology 13
Chapter 1 Industry overview 15
Summary 15
Introduction 16
Classification of pharmaceutical fine chemicals (PFCs) 17
Basic intermediates 18
Key intermediates 19
Active pharmaceutical ingredients 19
Demand for pharmaceutical fine chemicals 20
Supply of pharmaceutical fine chemicals 21
Production of pharmaceutical fine chemicals 23
Raw materials used for the production of PFCs 23
Manufacturing procedures 24
Current regulatory environment for pharmaceutical intermediates 25
GMP requirements 25
ICH Q7A 25
US GMP – Federal Food Drug and Cosmetic Act 26
EU GMP 26
China GMP – GMP for pharmaceutical products 28
India GMP – Drugs and cosmetics rules Schedule M 29
Drug Price Competition and Patent Term Restoration Act (‘Hatch-Waxman Act’) 29
REACH 30
Key deals and alliances in the global pharmaceutical fine chemicals market 31
Chapter 2 Market overview 33
Summary 33
Introduction 34
Market dynamics 35
Global market size and structure 35
Regional distribution 37
Future outlook of the global PFC market 38
Drivers and resistors of PFC industry 41
Drivers of the PFC industry 42
Resistors of the PFC industry 44
Chapter 3 Recent trends in the pharmaceutical fine chemicals industry 46
Summary 46
Introduction 47
Increasing pricing pressure on PFC companies 48
Downturn in the innovative API market; upturn in the generic API market 48
Increasing PFC outsourcing is creating new growth opportunities 51
Recent innovations in the PFC manufacturing processes 52
Small molecule production technologies 52
Biotechnological manufacturing methods 55
HPAPIs 56
Antibody-drug conjugates 57
Relocation to emerging and fast growing markets 57
Chapter 4 Competitive landscape 59
Summary 59
Introduction 60
Competitive landscape 60
Capability analysis 61
Albemarle Corporation 62
Company overview 62
Business segmentation 62
Financial performance 63
Growth strategy 63
BASF 64
Company overview 64
Business segmentation 64
Financial performance 66
Growth strategy 66
Boehringer Ingelheim 67
Company overview 67
Business segmentation 68
Financial performance 68
Growth strategy 69
Cambrex 69
Company overview 69
Business segmentation 69
Financial performance 70
Growth strategy 70
DSM 71
Company overview 71
Business segmentation 72
Financial performance 73
Growth strategy 74
Evonik 76
Company overview 76
Business segmentation 76
Financial performance 76
Growth strategy 78
Lonza 79
Company overview 79
Business segmentation 79
Financial performance 80
Growth strategy 81
Novasep 83
Company overview 83
Business segmentation 83
Financial performance 84
Growth strategy 84
Sigma-Aldrich 84
Company overview 84
Business segmentation 84
Financial performance 85
Growth strategy 85
Sumitomo Chemical 86
Company overview 86
Business segmentation 87
Financial performance 88
Growth strategy 88
Other major PFC companies 89
Archimica 89
Daiichi Fine Chemical 90
KemFine 90
Saltigo 91
Siegfried 92
Abbreviations 93

Table of figures
Figure 2: Classification of chemicals based on functionality and industrial applications 18
Figure 3: Supply chain of pharmaceutical fine chemicals 22
Figure 3: Relationship between the industries involved in the PFC market 34
Figure 4: Supply areas of pharmaceutical intermediates in 2009 38
Figure 5: Supply areas of Pharmaceutical intermediates in 2015 39
Figure 6: Drivers and resistors of pharmaceutical fine chemical industry 41
Figure 7: Pharmaceutical industry trends influencing the PFC industry 48
Figure 8: Effect of patent cliff on the API market 49
Figure 9: Capability analysis of the leading 10 PFC companies 61
Figure 10: Albemarle’s fine chemicals division net sales 63
Figure 11: Cambrex’s fine chemicals sales ($m), 2010 70
Figure 12: DSM’s pharmaceutical division net sales ($m), 2010 74
Figure 13: Evonik’s chemical division net sales ($m), 2010 78


Table of tables
Table 1: Differentiating characteristics of commodities, fine chemicals and specialty chemicals 17
Table 2: List of important basic pharmaceutical intermediates and their applications 19
Table 3: List of major natural sources used in the synthesis of APIs 23
Table 4: List of major petrochemical products used in the synthesis of APIs 23
Table 5: Global pharmaceutical market by country ($m), 2009 36
Table 6: Forecast sales performance of pharmaceutical fine chemicals, 2010–2015 39
Table 7: Patent expiries of key pharmaceutical compounds during 2010–2015 50
Table 8: Performance of leading PFC companies ($m), 2009 60
Table 9: BASF financial performance by segment ($m), 2009 66
Table 10: Boehringer Ingelheim financial performance by segment ($m), 2009 68
Table 11: DSM financial performance by segment ($m), 2009 73
Table 12: Evonik’s Chemical division sales ($m), 2009 77
Table 13: Lonza financial performance ($m), 2009 80